Skip to main content

Table 5 Cox univariate analysis of progression-free survival including IHC markers, Wald's test

From: Clinical, pathological, and comprehensive molecular analysis of the uterine clear cell carcinoma: a retrospective national study from TMRG and GINECO network

Variables

 

N

HR

95 CI

p-value

ER

Pos vs neg

41

1.39

0.36–5.26

0.63

PR

Pos vs neg

41

0.81

0.10–6.25

0.84

GH2AX

Continuous

41

0.99

0.98–1.02

0.97

EZH2

Continuous

41

1.01

0.99–1.03

0.09

P16

Pos vs neg

41

5.88

1.56–25

0.009

P53

Pos vs neg

41

0.58

0.13–2.70

0.49

PTEN

Pos vs neg

41

1.75

0.53–5.88

0.35

PDL1

Pos vs neg

41

0.04

0–1000

0.55

MMRd

Yes vs no

41

1.01

0.27–3.84

0.99